TY - JOUR
KW - Adult
KW - Analgesics, Opioid/adverse effects
KW - Buprenorphine/therapeutic use
KW - Comorbidity
KW - Cross-Sectional Studies
KW - Female
KW - Health service use
KW - Humans
KW - Injections, Intramuscular
KW - Male
KW - Methadone/therapeutic use
KW - Middle Aged
KW - Multi-morbidity
KW - Naltrexone
KW - Naltrexone/administration & dosage
KW - Narcotic Antagonists/administration & dosage
KW - Opiate agonist treatment
KW - opioid use disorder
KW - Opioid-Related Disorders/drug therapy/epidemiology/psychology
KW - Treatment Outcome
KW - United States Department of Veterans Affairs/trends
KW - United States/epidemiology
KW - Veterans
KW - Veterans Health/trends
KW - Veterans/psychology
AU - M. M. Kelly
AU - E. Reilly
AU - T. Quinones
AU - N. Desai
AU - R. Rosenheck
A1 - 
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use; Financing & Sustainability
CY - Ireland
DO - 10.1016/j.drugalcdep.2017.10.017
JF - Drug and alcohol dependence
PB - . Published by Elsevier B.V
PP - Ireland
PY - 2018
SN - 1879-0046; 0376-8716
SP - 111
EP - 117
EP - 
T1 - Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration
T2 - Drug and alcohol dependence
TI - Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration
U1 - Opioids & Substance Use; Financing & Sustainability
U2 - 29245103
U3 - 10.1016/j.drugalcdep.2017.10.017
VL - 183
VO - 1879-0046; 0376-8716
Y1 - 2018
ER -